Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events. Zhang S, Zhang R, Xia Y, Cao D, et al. PLoS One 2025;20:e0336767.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang S, Zhang R, Xia Y, Cao D, et al. Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events. PLoS One 2025;20:e0336767.
PMID: 41259313